Ultima Genomics
Ultima Genomics is a US-based genomics technology company that develops ultra-high-throughput, low-cost DNA sequencing platforms (the UG 100/UG200 series). Its novel sequencing architecture enables population-scale genomics to advance biological research and improve human health.
Analytics date: 09.10.2026
Basic information
Head office
4209 Technology Drive, Fremont, CA 94538, United StatesHead officeGeography of business
United States of America- Netherlands
- Germany
Geography of businessDate of the last round
Last round 06/2022Date of the last roundTotal funds raised
$613.8M+Total funds raisedPrice per share
$50.14Price per sharePrice per share. Based on the latest known transaction. It is not an offer or investment recommendation.
Analytics date: 09.10.2026
Financial indicators
000000
0000000 0 000 00 0 0 0 000 00 0 00000000 0000 0 0000000000000000000000000000000
000 000
00 0 000 0 00 0 0 0 000 0000 00 0000 000000000000000000
0 0 0000
0 00 0 0 0 0 0 0 0 0 000 00 000 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
0 0 00000
00 00 00 0 0 0 0 000 000000 0 000 00 00 00000 000 0 0 0 00 00 0000 00000 00 0 0 0 0000000000000000000000000000000000
0 0000
00 0 0 0 00 0 0000 00 00 0 00 000 0000 00000 0 00 000 0 00 0 00 0 0 000 0 00 0 000000 00 0 000000000000000000000000000000000000000000
0 00 00
00 0 00000 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
000000 0000000 00000 0000 000000000 00000 00000000 0000000 000000000 000000000000 0000000 000000000 00000 000 00000000 000 0000 0000000000000 00000000 00 00000 000000 00000 00000000000 000000 000000000 00000000 00000 000000 000 00000 00000 00000000 0000000 00000 00000 0000000000 000 00000 00000000000 0 000 0000 00000000000 00000000 0000000 00000 000000 00000 00000000 00000 00000000000 0000 0000000 00000 0000 0000000
00000 00000 00000 000 00000 00000000000 00000000000 00000 00000 0000000000 00000000000 00000 0000 0000 00000000 0000000 000000000 000 000 00000 0000 0000000 0000000 00000000000 0000000000 00000000000 0000000000 0000000000 00000000 00000 00000000 000000 000000 00000 0000 000 0000000 0000000 00000000000 000000000 00000000 00000000000 00000000000 000000 00000000 00000000 00000 0000000000 0000000 000 00000000000000 000000 0000000 0000 000000 000 0000 00000 000000000 0000 0000000 000 000000 00000000 0000000000000 00000 000000000000000
0000000 00 000000000 0000000000 000 00000 0000000000 00000000 000 0000000000 0000000 00000000 00000000000 0000000000 0000000 00000 000 00000 0000 00000 000 0000 0000000 000000 0000 00000 000000 000000 0000000 00000 0000
000000000 00000 00000000 0000000 000000000 000000000000 0000000 000000000 00000 000 00000000 000 0000 0000000000000 00000000 00 00000 000000 00000 00000000000 000000 000000000 00000000 00000 000000 000 00000 00000 00000000 0000000 00000 00000 0000000000 000 00000 00000000000 0 000 0000 00000000000 00000000 000 0000 000000 00000 0000 000000000 000000000000 000 00000000 0000000 00000 000000000 00 0000000 000000 00000000 000000000 000000 000000 0000000000 00000 000000000000 00000000 00000 00000 00000 0000 000 0000000000 000000000000 000000 0000000000 0000 00000000000000 00000000 00000000 000 00 000000000
Request price information
Key financial indicators
| Revenue |
| Employees | |
| 0 0000 | ... |
| Volume | |
| 000 0 00 | ... |
Competitor Analysis
Comparison to other companies in the industry.
| Name | Evaluation |
| Private companies | |
Isomorphic Labs | ... |
Colossal Biosciences | $ 5.2B |
NaturalCycles | ... |
Flo Health | $ 1B |
Clue | $ 70M |
| Traded companies | |
Recursion Pharmaceuticals | $ 2.3B |
Schrödinger | $ 2B |
Relay Therapeutics | $ 4B |
Flow Health | $ 6.8B |
Tempus AI | $ 12.6B |